Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

Li Cao; Haiyan Sun; Hongmei Wu; Qingguo Lü; Alexis M. Mckee

doi:10.1002/14651858.CD011759

Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

Li Cao
, Haiyan Sun
, Hongmei Wu
, Qingguo Lü
, Alexis M. Mckee

Research output: Contribution to journal › Article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7% to 6.4%.

Original language	English
Article number	CD011759
Journal	Cochrane Database of Systematic Reviews
Volume	2015
Issue number	6
DOIs	https://doi.org/10.1002/14651858.CD011759
State	Published - Jun 24 2015

Access to Document

10.1002/14651858.CD011759

Cite this

@article{2c2004ca2dbb499ab8e4ca377ba4cde2,

title = "Pioglitazone for adults with high risk of developing type 2 diabetes mellitus",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7\% to 6.4\%.",

author = "Li Cao and Haiyan Sun and Hongmei Wu and Qingguo L{\"u} and Mckee, \{Alexis M.\}",

note = "Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",

year = "2015",

month = jun,

day = "24",

doi = "10.1002/14651858.CD011759",

language = "English",

volume = "2015",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

number = "6",

}

TY - JOUR

T1 - Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

AU - Cao, Li

AU - Sun, Haiyan

AU - Wu, Hongmei

AU - Lü, Qingguo

AU - Mckee, Alexis M.

PY - 2015/6/24

Y1 - 2015/6/24

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7% to 6.4%.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of pioglitazone for adults with high risk of developing type 2 diabetes, which includes impaired glucose tolerance (IGT), impaired fasting blood glucose (IFG) and glycosylated haemoglobin A1c (HbA1c) measurements 5.7% to 6.4%.

UR - https://www.scopus.com/pages/publications/85041798152

U2 - 10.1002/14651858.CD011759

DO - 10.1002/14651858.CD011759

M3 - Article

AN - SCOPUS:85041798152

SN - 1469-493X

VL - 2015

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 6

M1 - CD011759

ER -

Pioglitazone for adults with high risk of developing type 2 diabetes mellitus

Abstract

Access to Document

Other files and links

Fingerprint

Cite this